药品详细
Bambuterol(班布特罗)
化学结构式图
中文名
班布特罗
英文名
Bambuterol
分子式
C18H29N3O5
化学名
3-[2-(tert-butylamino)-1-hydroxyethyl]-5-[(dimethylcarbamoyl)oxy]phenyl N,N-dimethylcarbamate
分子量
Average: 367.44
Monoisotopic: 367.210721053
Monoisotopic: 367.210721053
CAS号
81732-46-9
ATC分类
R03C 未知
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
Bambuterol is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline.
生产厂家
封装厂家
参考
Synthesis Reference | Not Available |
General Reference | Not Available |
剂型
规格
化合物类型
Type | small molecule |
Classes |
|
Substructures |
|
适应症
药理
Indication | For the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. | ||||||||
Pharmacodynamics | Bambuterol is a long acting beta2-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline. Bambuterol causes smooth muscle relaxation, resulting in dilation of bronchial passages. | ||||||||
Mechanism of action | The pharmacologic effects of bambuterol are at least in part attributable to stimulation through beta-adrenergic receptors (beta 2 receptors) of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. | ||||||||
Absorption | Bioavailability is 20% following oral administration. | ||||||||
Volume of distribution | Not Available | ||||||||
Protein binding | Not Available | ||||||||
Metabolism |
Hepatic, extensive. Further metabolized to terbutaline by plasma cholinesterase.
Important The metabolism module of DrugBank is currently in beta. Questions or suggestions? Please contact us.
|
||||||||
Route of elimination | Not Available | ||||||||
Half life | 13 hours for bambuterol and 21 hours for the primary active metabolite terbutaline. | ||||||||
Clearance | Not Available | ||||||||
Toxicity | Not Available | ||||||||
Affected organisms |
|
||||||||
Pathways | Not Available |
理化性质
Properties | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | ||||||||||||||||||||||||||||||||||||||||||
Experimental Properties | Not Available | ||||||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
Drug | Interaction |
---|---|
Indacaterol | Concomitant use with other inhaled, long acting beta2-adrenergic drugs may result in an overdose. Adverse cardiovascular effects and fatalities have been associated with excessive use of inhaled sympathomimetic drugs. |
食物相互作用
Not Available